1 / 7

Dementia Drugs Market Projected to Reach $19.7 Billion by 2031

Allied Market Research published a report, titled, "Dementia Drugs Market by Indication (Lewy Body Dementia, Parkinsons Disease Dementia, Alzheimers Disease, Vascular Dementia, Other Indications), by Drug Class (Cholinesterase Inhibitors, NMDA Antagonists and its Combination Drugs), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031".<br><br>Know More- https://www.alliedmarketresearch.com/dementia-drugs-market-A12014

Télécharger la présentation

Dementia Drugs Market Projected to Reach $19.7 Billion by 2031

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. GET PDF GLOBAL OPPORTUNITY  ANALYSIS AND INDUSTRY  FORECAST 2021-2031 Dementia Drugs Market   KNOW MORE

  2. CURRENT AND FUTURE MARKET SCENARIO • The global dementia drugs market size was valued at $8.7 billion in 2021. • The global dementia drugs market is projected to reach $19.7 billion by 2031. • The global dementia drugs market registering a CAGR of 8.5% from 2022 to 2031.

  3. FACTORS CONTRIBUTING TO MARKET GROWTH • Increase in the prevalence of Alzheimer's disease, advancement in R&D activities for drug development, rise in the adoption of early diagnosis, the growing geriatric population, increase in investment in R&D by players, presence of robust pipeline candidates, increase in public awareness about the disease prevention in developing regions, and the surge in demand for personalized medicines drive the growth of the global dementia drugs market. For more detail: Click Here

  4. GEOGRAPHICAL OVERVIEW • Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. • Region-wise,dementia drugs market analysis across North America, Europe, asia-Pacific and LAMEA. North America has the highest market share, with $3657.17 million in 2021, and is estimated to reach $7270.88 million by 2031, registering a CAGR of 7.1% during the forecast period, owing to investments made by key players for various R&D activities as well as launch of new products in the U.S.  • In addition, increase in awareness among consumers for the adoption of dementia drugs is further anticipated to stimulate the growth of the dementia drugs industry in North America. On the other side, Asia-Pacific is projected to register the highest CAGR of 10.6% during the dementia drugs market forecast period. 

  5. LEADING MARKET PLAYERS • AbbVie Inc. • Apotex Inc. • Aurobindo Pharma Limited • Biogen Idec Inc. • Eisai Global • Eli Lilly and Company • F. Hoffmann-La Roche Ltd. • Johnson & Johnson • Novartis AG • Teva Pharmaceuticals

  6. A Report Titled “Dementia Drugs Market- Global Opportunities And Forecasts, 2021– 2031” Has Been Recently Published By Allied Market Research. It Makes An In-depth Analysis Of Current Trends, Drivers, And Restraining Factors That Affect Financial Ratios Relevant To The Industry. Company Profiles For Key Vendors In Business Builds A Comprehensive Picture Of Profitable Opportunities From Stakeholder’s Perspective. To Know More AboutDementia Drugs Market- Opportunities and Forecasts, 2021– 2031 Read More Purchase Enquiry -Click Here Follow Allied Market Research

  7. ABOUT ALLIED MARKET RESEARCH Allied Market Research (AMR) Is A Full-service Market Research And Business-consulting Wing Of Allied Analytics LLP Based In Portland, Oregon. Allied Market Research Provides Global Enterprises As Well As Medium And Small Businesses With Unmatched Quality Of "Market Research Reports" And "Business Intelligence Solutions." AMR Has A Targeted View To Provide Business Insights And Consulting To Assist Its Clients To Make Strategic Business Decisions And Achieve Sustainable Growth In Their Respective Market Domain.We Are In Professional Corporate Relations With Various Companies And This Helps Us In Digging Out Market Data That Helps Us Generate Accurate Research Data Tables And Confirms Utmost Accuracy In Our Market Forecasting. Each And Every Data Presented In The Reports Published By Us Is Extracted Through Primary Interviews With Top Officials From Leading Companies Of Domain Concerned. Our Secondary Data Procurement Methodology Includes Deep Online And Offline Research And Discussion With Knowledgeable Professionals And Analysts In The Industry. Contact: David Correa5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesToll Free: +1-800-792-5285UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: +1-855-550-5975help@alliedmarketresearch.comWeb: https://www.alliedmarketresearch.com

More Related